Loading…
Loading…
Monarch posts y/y growth in Q2 sales, earnings and margins, driven by higher cement volumes and lower production costs, though ready-mixed concrete weakens.
The Monarch Cement Company remains a compelling 'buy' due to its attractive valuation and robust balance sheet. MCEM delivered 27.6% revenue growth and a surge in net profit to $11.3 million in Q1 2026, driven by higher volumes and pricing. Despite macroeconomic headwinds and softening construction spending, MCEM's debt-free status and significant cash reserves underpin resilience.
Monarch Cement's long-life reserves, capacity investments, expansion strategy and discounted valuation make it a compelling building materials stock to buy.
MCEM's Q1 earnings surge y/y on higher cement and concrete volumes, while margins expand amid stronger construction demand.
The Monarch Cement Company remains a "buy" due to its strong balance sheet and attractive valuation, despite recent price appreciation. MCEM outperformed the S&P 500, rising 76.3% since December 2023, with recent quarterly improvements in revenue and profitability. Despite industry headwinds and a challenging year for U.S. cement demand, MCEM trades near the low end of peer valuation multiples and boasts a net cash position.
MCEM's 2025 results show declining revenues and earnings as weak ready-mix demand offsets pricing gains and cost controls.
The Monarch Cement Co. (OTCMKTS:MCEM - Get Free Report)'s stock price passed above its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $234.55 and traded as high as $241.97. Monarch Cement shares last traded at $241.50, with a volume of 518 shares changing hands. Monarch
The Monarch Cement Co. (OTCMKTS:MCEM - Get Free Report) was the recipient of a large growth in short interest in January. As of January 15th, there was short interest totaling 232 shares, a growth of 42.3% from the December 31st total of 163 shares. Currently, 0.0% of the company's shares are short sold. Based on
No recent filings indexed.